Whole Genome and Exome Sequencing Markets See Rapid Growth with Focus on Newborn Screening, Direct to Consumer Testing, and Advanced Technologies from 2023 to 2027 [Yahoo! Finance]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The global market for Whole Genome and Exome Sequencing is witnessing a substantial surge, sparked by advances in genetic testing technologies and a significant reduction in sequencing costs. This growth is paralleled by an increase in applications ranging from newborn screening to direct-to-consumer tests, highlighting a transformative phase akin to the early days of the internet. As the industry evolves, a recently published research publication provides comprehensive insights into the market trends, including an assessment of applications by organism and product type. The shifts in the market are examined, with a spotlight on high-growth sectors and the emergence of direct-to-consumer genetic testing as a potent market force. The research navigates the intricate landscape of Whole Genome and Exome Sequencing, offering a clear and concise understanding of the technol
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker [Yahoo! Finance]Yahoo! Finance
- Vizgen Announces Significant Win in Ongoing Patent Litigation Against 10x Genomics and Harvard University [Yahoo! Finance]Yahoo! Finance
- International Markets and 10x Genomics (TXG): A Deep Dive for Investors [Yahoo! Finance]Yahoo! Finance
- 10x Genomics to Present at the BofA Securities 2024 Healthcare ConferencePR Newswire
- 10x Genomics First Quarter 2024 Earnings: In Line With Expectations [Yahoo! Finance]Yahoo! Finance
TXG
Earnings
- 4/30/24 - Miss
TXG
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/26/24 - Form DEFA14A
- TXG's page on the SEC website